Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

iSpecimen (ISPC) Revenue: 2020-2025

Historic Revenue for iSpecimen (ISPC) over the last 6 years, with Sep 2025 value amounting to $106,592.

  • iSpecimen's Revenue fell 96.00% to $106,592 in Q3 2025 from the same period last year, while for Sep 2025 it was $3.4 million, marking a year-over-year decrease of 67.73%. This contributed to the annual value of $9.3 million for FY2024, which is 6.42% down from last year.
  • iSpecimen's Revenue amounted to $106,592 in Q3 2025, which was down 85.05% from $713,135 recorded in Q2 2025.
  • iSpecimen's Revenue's 5-year high stood at $3.0 million during Q1 2021, with a 5-year trough of $106,592 in Q3 2025.
  • In the last 3 years, iSpecimen's Revenue had a median value of $2.3 million in 2024 and averaged $1.9 million.
  • In the last 5 years, iSpecimen's Revenue spiked by 76.21% in 2024 and then tumbled by 96.00% in 2025.
  • Quarterly analysis of 5 years shows iSpecimen's Revenue stood at $2.5 million in 2021, then rose by 16.18% to $3.0 million in 2022, then decreased by 13.05% to $2.6 million in 2023, then tumbled by 42.70% to $1.5 million in 2024, then tumbled by 96.00% to $106,592 in 2025.
  • Its Revenue was $106,592 in Q3 2025, compared to $713,135 in Q2 2025 and $1.1 million in Q1 2025.